Literature DB >> 6271373

Antagonism of presynaptic adenosine receptors by theophylline 9-beta-D-riboside and 8-phenyltheophylline.

A S Clanachan.   

Abstract

Theophylline 9-beta-D-riboside and 8-phenyltheophylline were evaluated as presynaptic adenosine receptor antagonists in the rat vas deferens in vitro. Stimulation of presynaptic adenosine receptors, which results in an inhibition of the twitch response to electrical field stimulation, was achieved with 2-chloroadenosine, an adenosine analogue that appears not to be a substrate for the adenosine transport system. The presynaptic inhibitory action of 2-chloroadenosine was antagonized by theophylline (10 and 100 microM) and by 8-phenyltheophylline (10 microM) but not by theophylline 9-beta-D-riboside (100 microM). It is concluded that the addition of a ribose moiety to theophylline does not enhance the antagonist potency of the molecule but actually renders the compound inactive. However, 8-phenyltheophylline is approximately three times more potent than theophylline at presynaptic adenosine receptors.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6271373     DOI: 10.1139/y81-091

Source DB:  PubMed          Journal:  Can J Physiol Pharmacol        ISSN: 0008-4212            Impact factor:   2.273


  3 in total

1.  Classification of adenosine receptors mediating antinociception in the rat spinal cord.

Authors:  J Sawynok; M I Sweeney; T D White
Journal:  Br J Pharmacol       Date:  1986-08       Impact factor: 8.739

2.  The mechanism of action of AMP-induced inhibition of sympathetic neurotransmission in the isolated vas deferens of the rat and guinea-pig.

Authors:  H H Dalziel; P Sneddon
Journal:  Br J Pharmacol       Date:  1988-07       Impact factor: 8.739

3.  Relative binding orientations of adenosine A1 receptor ligands--a test case for Distributed Multipole Analysis in medicinal chemistry.

Authors:  E M van der Wenden; S L Price; R P Apaya; A P IJzerman; W Soudijn
Journal:  J Comput Aided Mol Des       Date:  1995-02       Impact factor: 3.686

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.